Mucormycosis infection in severe COVID‐19 patient with multiple underlying health conditions
Abstract Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID‐19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID‐19 and mucormycosis.
Saved in:
Main Authors: | Zahra Heydarifard, Moslem Safaei, Sevrin Zadheidar, Soroush Ehsan, Nazanin Zahra Shafiei‐Jandaghi |
---|---|
Format: | article |
Language: | EN |
Published: |
Wiley
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/cb800dc93e534d55922e65f5b9af7166 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study
by: Ángel Estella, et al.
Published: (2021) -
Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19
by: Helena Codina, et al.
Published: (2021) -
Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China
by: Junyan Qu, et al.
Published: (2021) -
COVID-19 Clinical Profile in Latin American Migrants Living in Spain: Does the Geographical Origin Matter?
by: Abiu Sempere, et al.
Published: (2021) -
A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19
by: Johanna Reinold, et al.
Published: (2021)